Treatment of recurrent focal segmental glomerular sclerosis posttransplant with a multimodal approach including high-galactose diet and oral galactose supplementation

Transplantation

Volumn 91, Issue 6, 2011, Pages

  Jhaveri, Kenar D ^a   Naber, Tamim H ^a   Wang, Xiaotong ^a   Molmenti, Ernesto ^a   Bhaskaran, Madhu ^a   Boctor, Fouad N ^a   Trachtman, Howard ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; GALACTOSE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADULT; CASE REPORT; DETERIORATION; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LETTER; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REPEATED DRUG DOSE;

ADMINISTRATION, ORAL; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; FEMALE; GALACTOSE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MIDDLE AGED; RECURRENCE;

EID: 79952767361     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182088b67     Document Type: Letter

References (4)

1. Savin VJ, McCarthy ET, Sharma R, et al. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 2008; 151: 288.
2. Savin VJ, Sharma R, Sharma M, et al. Circulating factor increasing glomerular permeability in recurrent focal segmental glomerulosclerosis. N Eng J Med 1996; 334: 878.
3. De Smet E, Rioux JP, Ammann H, et al. FSGS permeability factor-associated nephrotic syndrome: Remission after oral galactose therapy. Nephrol Dial Transplant 2009; 24: 2938.
4. Garin EH, Mu W, Arthur JM, et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010; 78: 296.